Immunophenotyping is critical to the diagnosis of MS, as it can be difficult to differentiate from other diagnoses including lymphoma using conventional light microscopy.
A 47-year-old male with no past history developed abdominal distension and fatigue, and was found to have anemia (hemoglobin 7.4 g/dL), thrombocytopenia (platelets 74 × 10 9 /L), and leukocytosis (WBC 33 × 10 9 /L) with 8% circulating blasts. Imaging showed marked hepatosplenomegaly and diffuse bulky lymphadenopathy ( Figure 1 ).
Bone marrow biopsy and clinical presentation were consistent with primary myelofibrosis ( Figure 2 ). As lymphadenopathy is rare in PMF, he underwent axillary lymph node biopsy which demonstrated effacement by immature-appearing cells ( Figure 3 ). Flow cytometry showed an immature cell population (CD45 dim) that was negative for CD34, CD56, CD117, and MPO; strongly positive for CD4; and variably positive for CD10, CD33, HLA-DR, CD68, CD123, and Ecadherin, consistent with myeloid sarcoma (MS). The patient did not respond to induction chemotherapy with daunorubicin, cytarabine, and cladribine, but lymphadenopathy resolved after three cycles of decitabine and ruxolitinib. He progressed after six cycles, and was transitioned to azacytidine and venetoclax. He proceeded to allogeneic stem cell transplant, but died from veno-occlusive disease on day +11.
While MS commonly affects lymph nodes, 1 it rarely presents with diffuse involvement as in this case. Immunophenotyping is critical in diagnosing MS, as it can be difficult to differentiate from other diagnoses, including lymphoma, using light microscopy. 2 
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